Enzolytics Stock

Enzolytics EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Enzolytics (ENZC) as of Aug 5, 2026 is -62.44.

EV/FCF

-62.44

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Enzolytics is 2026 -62.44 . EV/FCF (Enterprise Value to Free Cash Flow) of Enzolytics was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Enzolytics Stock analysis

What does Enzolytics do? Enzolytics Inc is an innovative biotechnology company specializing in the development of effective therapies for combating infectious diseases and cancer. Enzolytics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzolytics stock

EV/FCF (Enterprise Value to Free Cash Flow) of Enzolytics is -62.44 in 2026.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Enzolytics since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Enzolytics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Enzolytics

All Key Metrics — Enzolytics